John E Finn

US Patent:

6348482, Feb 19, 2002

Filed:

May 5, 2000

Appl. No.:

09/566275

Inventors:

Milton L. Hammond - Somerville NJ
Aaron H. Leeman - Cranford NJ
Milana Maletic - Hoboken NJ
Gina M. Santorelli - Oceanport NJ
Sherman T. Waddell - Westfield NJ
John Finn - Stow MA
Michael Morytko - Framingham MA
Jason Hill - Auburndale MA
Dennis Keith - Montclair NJ

Assignee:

Merck Co., Inc. - Rahway NJ
Cubist Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A01N 4378

US Classification:

514370, 514377, 514394, 514398, 514399, 514424, 548193, 548233, 5483101, 5483315, 5483411, 548558

Abstract:

Compounds, pharmaceutically acceptable salts, and compositions thereof of the general formula: wherein Ar is aryl and heteroaryl; R , R , R , and R are hydrido, alkyl, cyano, heteroaryl, hydroxy, amino, acylamino, halo, alkoxy, aryloxy, carboxyamido, alkenyl, cycloalkyl, heterocyclyl, acyl, acyloxy, carboalkoxy, carboxy, thio, sulfinyl, sulfonyl and sulfoxy, R , R , R , and R are hydrido and lower alkyl; and Het is a nitrogen-containing heterocyclic ring.

US Patent:

6417217, Jul 9, 2002

Filed:

Aug 22, 2001

Appl. No.:

09/935033

Inventors:

Milton L. Hammond - Somerville NJ
Aaron H. Leeman - Cranford NJ
Milana Maletic - Hoboken NJ
Gina M. Santorelli - Oceanport NJ
Sherman T. Waddell - Westfield NJ
John Finn - Stow MA
Michael Morytko - Framingham MA
Siya Ram - Winchester MA
Dennis Keith - Montclair NJ

Assignee:

Merck Co., Inc. - Rahway NJ
Cubist Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 314184

US Classification:

514394, 514266, 514303, 514365, 514378

Abstract:

Transfer ribonucleic acid (tRNA) synthetase inhibitors, salts, and pharmaceutically acceptable compositions thereof of the general formula: wherein Ar is aryl and heteroaryl; L is âC(O)N(Q)CH â, or âCR R OCR R â; Q is hydrido, â(CH ) CO H and â(CH ) CO CH , m is 1, 2, 3, and 4; R , R , R , R , R , R and R are hydrido or lower alkyl; wherein Het is a heterocyclic moiety, the inhibitors are suitable for use as antimicrobial agents.

US Patent:

6545015, Apr 8, 2003

Filed:

Aug 22, 2001

Appl. No.:

09/934743

Inventors:

Milton L. Hammond - Somerville NJ
Aaron H. Leeman - Cranford NJ
Milana Maletic - Hoboken NJ
Gina M. Santorelli - Oceanport NJ
Sherman T. Waddell - Westfield NJ
John Finn - Stow MA
Michael Morytko - Framingham MA
Jason Hill - Auburndale MA
Dennis Keith - Montclair NJ

Assignee:

Merck Co., Inc. - Rahway

International Classification:

C07D21500

US Classification:

514303, 546118

Abstract:

Compounds, pharmaceutically acceptable salts, and compositions thereof of the general formula: wherein Ar is aryl and heteroaryl; R , R , R , and R are hydrido, alkyl, cyano, heteroaryl, hydroxy, amino, acylamino, halo, alkoxy, aryloxy, carboxyamido, alkenyl, cycloalkyl, heterocyclyl, acyl, acyloxy, carboalkoxy, carboxy, thio, sulfinyl, sulfonyl and sulfoxy, R , R , R , and R are hydrido and lower alkyl; and Het is a nitrogen-containing heterocyclic ring.

US Patent:

6579894, Jun 17, 2003

Filed:

Jun 17, 2002

Appl. No.:

10/173054

Inventors:

Milton L. Hammond - Somerville NJ
Aaron H. Leeman - Cranford NJ
Milana Maletic - Hoboken NJ
Gina M. Santorelli - Oceanport NJ
Sherman T. Waddell - Westfield NJ
John Finn - Stow MA
Michael Morytko - Framingham MA
Siya Ram - Winchester MA
Dennis Keith - Montclair NJ

Assignee:

Merck Co., Inc. - Rahway NJ
Cubist Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 314184

US Classification:

514394, 514266, 514303, 514365, 514378

Abstract:

Transfer ribonucleic acid (tRNA) synthetase inhibitors, salts, and pharmaceutically acceptable compositions thereof of the general formula: wherein Ar is aryl and heteroaryl; L is âC(O)N(Q)CH â, or âCR R OCR R â; Q is hydrido, â(CH ) CO H and â(CH ) CO CH , m is 1, 2, 3, and 4; R , R , R , R , R , R and R are hydrido or lower alkyl; wherein Het is a heterocyclic moiety, the inhibitors are suitable for use as antimicrobial agents.

US Patent:

7355513, Apr 8, 2008

Filed:

Dec 23, 2005

Appl. No.:

11/318141

Inventors:

Kenneth H. Brockel - Neptune NJ, US
Harry G. Ivory - Bordentown NJ, US
Fenton K. Yip - Edison NJ, US
John P. Finn - West Conshohocken PA, US
James E. Hagerman - Glen Mills PA, US

Assignee:

The United States of America as represented by the Secretary of the Army - Washington DC

International Classification:

G08B 1/08
H04Q 7/00
G01C 21/00
G01S 1/00

US Classification:

34053913, 34053911, 4554561, 4554042, 455 901, 701213, 701214, 34235706, 34235707

Abstract:

A survivor locator system allows for the detection of the location for a person who is lost and requires recovery and extraction from their current environment. By using a phase matched antenna set, a GPS receiver, and a handheld simplified beacon-equipped survival transponder, an estimated distance and bearing data set can be retrieved. If this data set estimation is then fed through an error reduction filter, such as a Kalman filtering algorithm, continually refined location coordinates can be generated, leading the search and rescue crew members to the survivor. The survivor locator system and methods provide a handheld survival radio with reduced complexity.

US Patent:

63333449, Dec 25, 2001

Filed:

May 5, 2000

Appl. No.:

9/566112

Inventors:

Milton L. Hammond - Somerville NJ
Aaron H. Leeman - Cranford NJ
Milana Maletic - Hoboken NJ
Gina M. Santorelli - Oceanport NJ
Sherman T. Waddell - Westfield NJ
John Finn - Stow MA
Michael Morytko - Framingham MA
Siya Ram - Winchester MA
Dennis Keith - Montclair NJ

Assignee:

Merck & Co. - Rahway NJ
Cubist Pharmaceuticals, Inc. - Cambridge MA

International Classification:

A61K 314184
A61K 31422
C07D40312
C07D41314
C07D41714

US Classification:

514394

Abstract:

Transfer ribonucleic acid (tRNA) synthetase inhibitors, salts, and pharmaceutically acceptable compositions thereof of the general formula: ##STR1## wherein Ar is aryl and heteroaryl; L is --C(O)N(Q)CH. sub. 2 --, or --CR. sup. 10 R. sup. 11 OCR. sup. 12 R. sup. 13 --; Q is hydrido, --(CH. sub. 2). sub. m CO. sub. 2 H and --(CH. sub. 2). sub. m CO. sub. 2 CH. sub. 3, m is 1, 2, 3, and 4; R. sup. 1, R. sup. 2, R. sup. 9, R. sup. 10, R. sup. 11, R. sup. 12 and R. sup. 13 are hydrido or lower alkyl; wherein Het is a heterocyclic moiety, the inhibitors are suitable for use as antimicrobial agents.

US Patent:

56354495, Jun 3, 1997

Filed:

Apr 7, 1995

Appl. No.:

8/418985

Inventors:

Charles M. Langevine - Brooklyn NY
John M. Finn - Mercerville NJ

Assignee:

American Cyanamid Company - Madison NJ

International Classification:

A01N 5730
C07F 940
C07F 938

US Classification:

504207

Abstract:

The present invention provides arylthioalkyl- and arylthioalkenylphosphonic acids and derivatives thereof having the structural formula I ##STR1## Further provided are compositions and methods comprising those compounds for the control of undesirable plant species.